Sponsor:
The University of Texas Health Science Center at San Antonio
Code:
NCT06246799
Conditions
Type 2 Diabetes (Adult Onset)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Tirzepatide
Pioglitazone
Sitagliptin
Metformin HCI XR
Brief summary:
Conditions
Type 2 Diabetes (Adult Onset)
Study ID
NCT06246799
Start date
Nov 7, 2024
Status verified date
Mar, 2026
Completion date
Jun 30, 2029
Anticipated
Primary completion date
Apr 30, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
256 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
experimental: Group IC
active comparator: Group II
active comparator: Group IA
active comparator: Group 1B
Interventions
Tirzepatide
Pioglitazone
Sitagliptin
Metformin HCI XR
Primary outcome measure
Central contacts
Locations
University Health System Texas Diabetic Institute
Recruiting
San Antonio, Texas, United States, 78207
Contacts
UT Health Science Center
Recruiting
San Antonio, Texas, United States, 78229
Sponsor
The University of Texas Health Science Center at San Antonio
Last update posted
Mar 10, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by The University of Texas Health Science Center at San Antonio on 2026-03-10.